Emerging Therapy

    Latest
    Dupixent
    Emerging Therapy

    FDA Approves Dupixent® as First Biologic for Treatment of Children Aged...

    News Wire ~ 3rd Party Press Release -
    Brusha-Brusha
    Emerging Therapy

    Allerdent Enables Patients to Maintain Seasonal Allergy Immunotherapy During COVID-19 Pandemic

    News Wire ~ 3rd Party Press Release -
    FARE OIT Webinar
    Emerging Therapy

    Oral Immunotherapy: What You Should Know, and What’s New (Webinar)

    Dave Bloom -
    Vial + Syringe
    Emerging Therapy

    Pending Litigation Shows Food Allergy Treatments in Development are Sometimes Overhyped

    Dave Bloom -
    NanoVax Platform
    Emerging Therapy

    BlueWillow Completes Preclinical Studies of Intranasal Peanut Allergy Vaccine

    Dave Bloom -
    Viaskin-Patch-Delay
    Emerging Therapy

    FDA Has Questions About Viaskin Peanut Efficacy, Delays Meeting with DBV...

    Dave Bloom -
    Nose
    Emerging Therapy

    ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...

    News Wire ~ 3rd Party Press Release -
    Viaskin-Patch
    Emerging Therapy

    FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment...

    News Wire ~ 3rd Party Press Release -
    Alladapt
    Emerging Therapy

    Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...

    News Wire ~ 3rd Party Press Release -
    EAT Grand Challenge
    Emerging Therapy

    End Allergies Together Announces Winners of $1 Million Grand Challenge to...

    News Wire ~ 3rd Party Press Release -
    1234...15Page 3 of 15
    SnackSafely.com

    Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

    We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

    Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

    Please see our Terms of service and Privacy Policy.

    SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

    ©2020 SnackSafely.com Inc. All rights reserved.